Reaction
Iris Neovascularisation reporting signals
As of the last recalculation, Iris Neovascularisation appears in 123 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is MELPHALAN HYDROCHLORIDE (PRR 115.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Melphalan Hydrochloride | 15 | 115.2 | 115.2 |
| Ranibizumab | 15 | 108.8 | 108.8 |
| Faricimab | 3 | 64.2 | 64.2 |
| Cenegermin-Bkbj | 3 | 43.0 | 43.0 |
| Aflibercept | 7 | 40.2 | 40.2 |